3rd Quarter - Report

BROWNSTEIN HYATT FARBER SCHRECK, LLP for NOVARTIS

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to cell and gene therapy Pharmaceutical pricing Issues related to the development of therapies for rare diseases Issues related to COVID-19

LobbyistCovered position, as disclosed
NADEAM ELSHAMI —
MARC LAMPKIN —
BRIAN MCKEON —
RADHA MOHAN —
JEROME MURRAY —
ZACHARY PFISTER —
BRIAN WILD —

Contacted: Office of the Vice President of the United States; HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP)

Medical/Disease Research/Clinical Labs MED

Issues related to cell and gene therapy Pharmaceutical pricing Issues related to the development of therapies for rare diseases Issues related to COVID-19

LobbyistCovered position, as disclosed
EMILY FELDER —

Contacted: HOUSE OF REPRESENTATIVES; Office of the Vice President of the United States; Executive Office of the President (EOP)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.